VOICED : Grupo chino Sinopharm anuncia que su vacuna contra el covid-19 es eficaz en un 79%

Sinopharm announced its COVID-19 vaccine is 79% effective. Due to controlled virus spread in China, trials were conducted in other countries. China aims to make vaccines a global public good. Sinopharm has five projects in phase three trials and has applied for approval. The vaccine's efficacy is lower than Pfizer-BioNTech and Moderna, which exceed 94%. AstraZeneca's vaccine, developed with Oxford, shows 70% efficacy, potentially reaching 100% with two doses.

What percentage of efficacy did Sinopharm announce for its COVID-19 vaccine?

• 100%

• 70%

• 94%

• 79%

Why did Sinopharm conduct vaccine trials in other countries?

• Due to controlled virus conditions in China

• To collaborate with other governments

• To test in diverse climates

• To reduce costs

How many Chinese vaccine projects are in the third phase of clinical trials?

• Seven

• Five

• Three

• Ten

Which vaccine has an efficacy rate of over 94%?

• Pfizer-BioNTech

• Sinopharm

• AstraZeneca

• Johnson & Johnson

What is the potential efficacy of AstraZeneca's vaccine with two doses?

• 70%

• 79%

• 94%

• 100%